about
Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virusA systematic bioinformatics approach for selection of epitope-based vaccine targetsGenomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practiceRat genotype influences quantitative and qualitative aspects of xenogeneic immune response to pig blood mononuclear cells.Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.Designing peptide-based HIV vaccine for Chinese.Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.Information technologies for vaccine research.Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines.Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches.Review: variability of host-pathogen interaction.Vaccine immunogenetics: bedside to bench to population.Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma.The facial evolution: looking backward and moving forward.The role of Toll-like receptor 4 polymorphisms in vaccine immune response.Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.Population coverage analysis of T-Cell epitopes of Neisseria meningitidis serogroup B from Iron acquisition proteins for vaccine design.Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature.The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems
P2860
Q27477942-FB0173B0-3856-4118-9CD2-99AE03B00E63Q27481378-533E2305-F4B5-45CA-98A8-C9F18407C2B6Q28543022-A82E28DE-9094-41FA-B604-53B8BC5325FCQ33246506-B15C0C49-54D1-4638-8F3F-C727868815BDQ33325499-3AB4F705-3DC1-40B5-9E64-45FC0C1BAF61Q33930413-4DAA20A4-CEA3-4C5F-A832-EDDAA964657BQ34057942-3102F1B5-E31A-4250-A569-0055A50E59D8Q35599606-3C38617C-58B6-488D-BB86-001224E430F7Q35906659-DCB810D6-0978-4B05-B67F-756EE8188F96Q36198676-E0CCC0FD-7353-4317-8337-15ACFEB78AB6Q36383797-3743B682-0D46-499A-A430-5E87B82F7618Q36899098-FE258781-7870-43DB-9AFD-A91500B8347BQ36980187-6EF7CB27-ABD1-4460-9B55-CFD01BBC9841Q37039235-10FB0F7D-5516-42DE-9255-232E9A3575EDQ37158293-F9610A4B-1713-4496-BE75-1D6542DA7DC1Q37615656-8BCCFCE8-3FCF-4872-A298-64795E5BCC11Q38049128-20DB4076-7CDA-4EA9-8D30-84CCBBFA20A2Q38396207-FF7579FF-B62A-4C9A-9C82-865C28CA14B6Q39221090-423697C7-4564-45F7-A045-A7C85708FB27Q42776796-563AD049-E0C9-4E3C-A26F-FA1292770498Q45870495-5057D382-21D5-4692-9A53-3893DA2F5D1EQ58049672-BA549F73-9B17-4C42-9D1A-9CD8859E130E
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Variation in vaccine response in normal populations.
@ast
Variation in vaccine response in normal populations.
@en
type
label
Variation in vaccine response in normal populations.
@ast
Variation in vaccine response in normal populations.
@en
prefLabel
Variation in vaccine response in normal populations.
@ast
Variation in vaccine response in normal populations.
@en
P2860
P356
P1433
P1476
Variation in vaccine response in normal populations.
@en
P2093
Robert M Jacobson
P2860
P304
P356
10.1517/14622416.5.4.417
P577
2004-06-01T00:00:00Z